AZD1080 - CAS 612487-72-6
Catalog number:
612487-72-6
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H18N4O2
Molecular Weight:
334.37
COA:
Inquire
Targets:
GSK-3
Description:
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively, shows >14-fold selectivity against CDK2, CDK5, CDK1 and Erk2.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
Georgievska B1, Sandin J, Doherty J, Mörtberg A, Neelissen J, Andersson A, Gruber S, Nilsson Y, Schött P, Arvidsson PI, Hellberg S, Osswald G, Berg S, Fälting J, Bhat RV. J Neurochem. 2013 May;125(3):446-56. doi: 10.1111/jnc.12203. Epub 2013 Mar 11.
Abnormal tau phosphorylation resulting in detachment of tau from microtubules and aggregation are critical events in neuronal dysfunction, degeneration, and neurofibrillary pathology seen in Alzheimer's disease. Glycogen synthase kinase-3β (GSK3β) is a key target for drug discovery in the treatment of Alzheimer's disease and related tauopathies because of its potential to abnormally phosphorylate proteins and contribute to synaptic degeneration. We report the discovery of AZD1080, a potent and selective GSK3 inhibitor that demonstrates peripheral target engagement in Phase 1 clinical studies. AZD1080 inhibits tau phosphorylation in cells expressing human tau and in intact rat brain. Interestingly, subchronic but not acute administration with AZD1080 reverses MK-801-induced deficits, measured by long-term potentiation in hippocampal slices and in a cognitive test in mice, suggesting that reversal of synaptic plasticity deficits in dysfunctional systems requires longer term modifications of proteins downstream of GSK3β signaling.
2.Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
Chen S1, Sun KX1, Feng MX1, Sang XB1, Liu BL1, Zhao Y1. Drug Des Devel Ther. 2016 Mar 18;10:1225-32. doi: 10.2147/DDDT.S102506. eCollection 2016.
BACKGROUND: Glycogen synthase kinase-3β (GSK-3β) is a multifunctional serine/threonine kinase that plays an important role in cancer tumorigenesis and progression. We investigated the role of the GSK-3β inhibitor AZD1080 in ovarian cancer cell lines.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related GSK-3 Products


CAS 280744-09-4 SB-216763

SB-216763
(CAS: 280744-09-4)

SB-216763 is  a glycogen synthase kinase-3 (GSK3) inhibitor, can maintain mouse embryonic stem cells (mESCs) in a pluripotent state in the absence of exogenous ...

CAS 188011-69-0 Bikinin

Bikinin
(CAS: 188011-69-0)

Bikinin is an ATP-competitive Arabidopsis GSK-3 inhibitor, and acts as a strong activator of brassinosteroid (BR) signaling.

CAS 327036-89-5 TDZD-8

TDZD-8
(CAS: 327036-89-5)

CAS 252917-06-9 CHIR-99021

CHIR-99021
(CAS: 252917-06-9)

CHIR-99021 (CT99021) is a glycogen synthase kinase 3β (GSK3β) inhibitor that has antiproliferative activity in vitro and in vivo. CHIR-99021 inhibits GSK-3 with...

CAS 264218-23-7 SB415286

SB415286
(CAS: 264218-23-7)

SB415286 is a potent GSK3α inhibitor with IC50 and Ki values of 78 nM and 31 nM,respectively.

CAS 252935-94-7 CHIR-98014

CHIR-98014
(CAS: 252935-94-7)

CHIR-98014 is a selective GSK3 inhibitor with IC50s of 0.65 nM and 0.58 nM for GSK-3α and GSK-3β; potentiate insulin activation of glucose transport and utiliza...

CAS 612487-72-6 AZD1080

AZD1080
(CAS: 612487-72-6)

AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively, shows >14-fold ...

CAS 603272-51-1 GSK-3 inhibitor 1

GSK-3 inhibitor 1
(CAS: 603272-51-1)

GSK-3 inhibitor 1 is a potent GSK-3 inhibitor.

CAS 865854-05-3 Tideglusib

Tideglusib
(CAS: 865854-05-3)

Tideglusib is a potent, selective and irreversible small molecule non-ATP-competitive GSK3 inhibitor that has been investigated as a potential treatment for Alz...

CAS 486424-20-8 AZD2858

AZD2858
(CAS: 486424-20-8)

Potent and highly selective Glycogen Synthase Kinase-3β (GSK3β; Ki value 4.9 nM) inhibitor for Alzheimer’s disease with good BBB permeability in a bovine endoth...

CAS 603288-22-8 LY2090314

LY2090314
(CAS: 603288-22-8)

LY2090314  is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) which plays an important role in many pathways, including initiation of protein synthesis...

CHIR-98023
(CAS: 252916-76-0)

CHIR-98023 is a glycogen synthase kinase 3 inhibitor developed for the treatment of Type 2 diabetes mellitus.

CAS 487021-52-3 AR-A014418

AR-A014418
(CAS: 487021-52-3)

CAS 1129669-05-1 IM-12

IM-12
(CAS: 1129669-05-1)

IM-12 is a selective GSK-3β inhibitor with IC50 of 53 nM, and also enhances canonical Wnt signalling.

CAS 1797989-42-4 CHIR99021 HCl

CHIR99021 HCl
(CAS: 1797989-42-4)

CHIR99021, also known as CT99021, is a GSK-3α/β inhibitor (IC50= 10 nM/6.7 nM) with antiproliferative activity in vitro and in vivo. CHIR-99021 has also been sh...

CAS 160807-49-8 Indirubin-3'-monoxime

Indirubin-3'-monoxime
(CAS: 160807-49-8)

Indirubin-3'-monoxime, a chemical derivative of indirubin, is an inhibitor of GSK-3β with dual affinity for CDK1/5 receptor. It significantly inhibited the prol...

CP21R7
(CAS: 125314-13-8)

CP21R7, a selective GSK-3β inhibitor, which could probably influence luciferase activity at some extent.

CAS 601514-19-6 NSC 405020

NSC 405020
(CAS: 601514-19-6)

Chemical Structure

CAS 612487-72-6 AZD1080

Quick Inquiry

Verification code

Featured Items